search button

Hepatocellular carcinomas promote tumor-associated macrophage M2-polarization via increased B7-H3 expression

  • Authors:
    • Fu-Biao Kang
    • Ling Wang
    • Dong Li
    • Yin-Ge Zhang
    • Dian-Xing Sun

  • View Affiliations

  • Published online on: November 4, 2014     https://doi.org/10.3892/or.2014.3587
  • Pages: 274-282
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

B7 family members are aberrantly expressed on the human hepatocellular carcinoma (HCC) cell surface, and induce local and systemic immunosuppression. Tumor-associated macrophages (TAMs) are a significant immune cell subpopulation in HCC and may be induced to express co-inhibitory molecules including B7 homologue 3 (B7-H3). In the present study, 79.3% of the HCC tissue samples showed high expression of B7-H3 which was positively correlated with the number of TAMs in the evaluated cancer tissues. Furthermore, high levels of TAMs or B7-H3 were associated with a shorter survival time of the HCC patients. In vitro, B7-H3 expression was upregulated at both the mRNA and protein levels in phorbol 12-myristate 13-acetate (PMA)-induced THP-1 cells cocultured with HepG2 cells in a Transwell system. In addition, B7-H3 promoted PMA-induced THP-1 cells to differentiate into the M2 phenotype, with evidence of increases in arginase 1 (Arg1), vascular endothelial cell growth factor (VEGF) and macrophage-derived chemokine (CCL22) mRNA following coculture with HepG2 cells. However, this phenomenon was abrogated through knockdown of B7-H3 by RNA interference or by blocking the signal transducer and activator of trans­cription 3 (STAT3) signaling pathway. Overall, these results suggest that the B7-H3-mediated STAT3 signaling pathway is an important mechanism for inducing M2-type polarization of TAMs, which accelerates HCC development. Our findings may support the development of novel therapeutic strategies for HCC patients through the skewing of the TAM phenotype by targeting the B7-H3 signaling pathway.
View Figures
View References

Related Articles

Journal Cover

January-2015
Volume 33 Issue 1

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 3.8
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 8.5
  • CiteScore Rank: Q1: #74/404 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.719
  • SCImago Journal Rank (SJR): 0.864
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Kang F, Wang L, Li D, Zhang Y and Sun D: Hepatocellular carcinomas promote tumor-associated macrophage M2-polarization via increased B7-H3 expression. Oncol Rep 33: 274-282, 2015.
APA
Kang, F., Wang, L., Li, D., Zhang, Y., & Sun, D. (2015). Hepatocellular carcinomas promote tumor-associated macrophage M2-polarization via increased B7-H3 expression. Oncology Reports, 33, 274-282. https://doi.org/10.3892/or.2014.3587
MLA
Kang, F., Wang, L., Li, D., Zhang, Y., Sun, D."Hepatocellular carcinomas promote tumor-associated macrophage M2-polarization via increased B7-H3 expression". Oncology Reports 33.1 (2015): 274-282.
Chicago
Kang, F., Wang, L., Li, D., Zhang, Y., Sun, D."Hepatocellular carcinomas promote tumor-associated macrophage M2-polarization via increased B7-H3 expression". Oncology Reports 33, no. 1 (2015): 274-282. https://doi.org/10.3892/or.2014.3587